Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KAI-1678 in postherpetic neuralgia
NCT01106716Phase 2Completed
- Sponsor
- KAI Pharmaceuticals
- Start
- Mar 2009
- Primary completion
- Mar 2010
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of KAI-1678 in postherpetic neuralgia (PHN), sponsored by KAI Pharmaceuticals. Started Mar 2009; status: completed.
02
Drugs
KAI-1678
03
Conditions
postherpetic neuralgia (PHN)
Beyond the preview
Go deeper on NCT01106716.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01106716.